Mylan Announces Intentions to Buy Sweden’s Meda for $7.2B By Sam | March 17, 2016 Generics giant Mylan N.V. has struck a tentative deal to purchase Swedish drugmaker Meda AB for $7.2 billion in cash and stock. Source: International Pharmaceutical Regulatory Monitor Posted in International Pharmaceutical Regulatory Monitor